Navigation Links
Regenicin CEO to Participate in Live Webcast at OneMedForum Business Development and Finance Conference, January 11th at 4:00 PM PST
Date:1/11/2011

LITTLE FALLS, N.J., Jan. 11, 2011 /PRNewswire/ -- Regenicin, Inc. (OTC Bulletin Board: RGIN) a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs, will present at the 4th annual OneMedForum at the Sir Francis Drake Hotel in San Francisco today, Tuesday, January 11th.  Regenicin's CEO, Randall McCoy, will present Regenicin's core business model and strategic approach for bringing new regenerative medicine products to market. The presentation will take place at 4:00 PM PST in the hotel's Renaissance Room and can also be viewed through a live webcast at the following link http://www.ustream.tv/channel/onemedforum.

The 4th Annual OneMedForum

OneMedForum San Francisco 2011, runs concurrently with the J.P. Morgan conference that provides efficient access to the companies that shape the future of the rapidly changing healthcare landscape. The conference's mission is to bring together investors, business development executives, and the brightest new ideas and emerging healthcare and life science companies. Panel sessions will provide Insights for investors to better understand and identify prospective investment opportunities among the 100+ emerging public and private companies that will present over the two and a half days.

About Regenicin

Regenicin, Inc., (OTC Bulletin Board: RGIN) is a biotechnology company specializing in the development of and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs. Regenicin, which was founded in 2010, has assembled a world class team with a proven track record for developing and bringing innovative medical devices and biotechnology produc
'/>"/>

SOURCE Regenicin, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regenicin COO Receives Citizenship Award from VFW Post 1 in Colorado
2. Regenicin Announces Closing of Private Placement Transaction
3. Regenicin Changes Its Ticker Symbol to RGIN.OB
4. Regenicin Presentation Now Available Online at RetailInvestorConferences.com
5. Regenicin to Present at Event Celebrating Advancements in Regenerative Medicine
6. Regenicin to Present Live at RetailInvestorConferences.com on November 4th
7. Regenicin Appoints Renowned New York Dermatologist, Dr. Gervaise Gerstner to Scientific Advisory Board
8. Regenicin to Form Scientific Advisory Board
9. Regenicin Names Former U.S. Marine Corp Operations Officer, Christopher Hadsall, Chief Operating Officer
10. Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO
11. Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/v7fdpx/argentina ) has announced ... - Growth, Trends & Forecasts (2014-2020)" report to ... market is estimated at $0.17 billion by 2018 at ... The near future will bring Biomedical sensors that ... These sensors can be set to trigger alerts when ...
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ( ... "Israel Biomedical Sensors Market - Growth, Trends & Forecasts ... The Israel Biomedical Sensors market is estimated at $0.19 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:8/31/2015)... , Aug. 31, 2015  For people with ... brighten their day. The biotechnology company, located in the ... one of the best potential therapies yet for people ... entitled, " Correction of Down syndrome and Edwards syndrome ... journal DNA Research . Elixirgen plans to develop ...
(Date:8/31/2015)... Aug. 31, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapies primarily in the ... the 30-day review period following the filing of ... indications with the U.S. Food and Drug Administration ... active. Logo -  http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
Breaking Biology Technology:Argentina Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts 2014-2020 2Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2New Down syndrome therapy discovered 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4
... Quarter-to-Quarter Revenue Gain Evidences Start of Turnaround ... for Core Business ... Agreements, IRVING, Texas, Aug. 14 Carrington,Laboratories, Inc. (Nasdaq: CARN ) reported ... in the year ago,period. The revenue in the quarter just ended, while 17 percent ...
... Summertime equals fun for a lot of,folks. ... (IBS), typical,summer fare could also mean aggravating their ... for IBS," has more on,what people with IBS ... IBS from,ruining their celebrations. Listen to this ...
... Medical,Technologies, Inc. (the "Company") (Nasdaq: CMED ), ... and markets advanced in-,vitro diagnostic products and high ... it will participate in the Morgan,Stanley,s 2007 China ... Date: August 21, 2007 China Medical Technologies, ...
Cached Biology Technology:Carrington Reports Second Quarter 2007 Results 2Carrington Reports Second Quarter 2007 Results 3Carrington Reports Second Quarter 2007 Results 4Carrington Reports Second Quarter 2007 Results 5Carrington Reports Second Quarter 2007 Results 6Carrington Reports Second Quarter 2007 Results 7
(Date:8/5/2015)... 2015 The biosensors market is proving highly ... into newer sectors, and development of devices resulting in ... has seen the entry of multiple participants each year ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... the Global Biosensors Market ( http://www.frost.com/nee9 ), finds ...
(Date:7/31/2015)... Den 10. internationale konference om Genomik (ICG-10, ... - 25. oktober i Shenzhen , ... i år. Siden starten i 2006 er ICB blevet ... og er en af de mest dynamiske, entusiastiske og ... nylige gennembrud og fremskridt inden for ,omik,-forskning, som yderligere ...
(Date:7/31/2015)... de 2015 La 10 th International Conference ... de BGI del 22 al 25 de octubre de 2015 en ... año, la conferencia celebra su décimo aniversario. Desde su inauguración ... de las reuniones anuales más influyentes del mundo en el ... dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... release is available in French . ... and dosage of antipsychotics may influence their efficacy, reported Philippe ... mentale de Montral and Universit de Montral. The efficacy of ... get into the bloodstream after being absorbed. Vincent and Kouassi ...
... healthy and then we weaken and die - that,s probably how ... the phenomenon of ageing shows an unexpected diversity of patterns and ... Denmark. Not all species weaken and become more likely ... likely to die with age, while others are not affected by ...
... The Children,s Hospital of Philadelphia have manipulated key biological ... of hemoglobin normally absent after the newborn period. Because ... in sickle cell disease (SCD), the cell culture findings ... the debilitating blood disorder. "Our study shows ...
Cached Biology News:How can we improve the efficacy of antipsychotics in the era of personalized pharmacotherapy? 2Surprising diversity in aging revealed in nature 2Surprising diversity in aging revealed in nature 3Flipping a gene switch reactivates fetal hemoglobin, may reverse sickle cell disease 2
Mouse Laminin-1 MAb (Clone AL-3)...
IEX-1 S/L (H-20)...
... reactivity with rat (100%), mouse ... pig (48%). Slight reactivity ... confirmed by Western blot versus ... Gia-1, Gia-2, rat Gia-3, bovine ...
IgG2b, k APC clone A95-1, Isotype Rat IgG2b, kappa, 0.1 mg ....
Biology Products: